跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gliclapro - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gliclapro
Approved
STANDARD
Gliclapro
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ee6b2093cfaee1b7
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
ee6b2093cfaee1b7
Drug Approval Philippines Name
Gliclapro
Product Name
Gliclapro
Registration Number
DRP-7630
Brand Name
Gliclapro
Generic Name
Gliclazide
Dosage Form
Modified-Release Tablet
Dosage Strength
80 mg
Manufacturer
Lloyd Laboratories, Inc.
Trader
Transcend Phils., Inc.
Issuance Date
28 October 2020
Expiry Date
01 October 2025
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ee6b2093cfaee1b7
Type
Standard
Back to Philippines FDA Approvals